Business Wire

Prytania Media Founders Reveal Two Additional AAA Studios

Share

Jeff Strain (co-founder ArenaNet, co-founder Undead Labs, Crop Circle Games, Possibility Space, co-founder and President of Studios, Prytania Media) and Annie Delisi Strain (co-founder Undead Labs, Crop Circle Games, Possibility Space, co-founder and CEO Prytania Media) are delighted to publicly reveal two AAA additions to the Prytania Media family of studios.

Fang & Claw is creating the next evolution of fantasy combat sports for the rapidly growing competitive-play market. With a $3M seed investment by Transcend Fund, the studio is built around a veteran team including:

  • Jeremy Gaffney, Studio Head (co-founder of Turbine Entertainment, Sr Director at Blizzard Entertainment)
  • Fleur Marty, Executive Producer (Executive Producer at WB Games Montreal)
  • Chris Venturini, Creative Director (Animation Director at ArenaNet, Gameplay Lead at Undead Labs)
  • Horia Dociu, Art Director (Studio Art Director at 343 Industries and Sucker Punch Productions)
  • Ben Scott, Technical Director (Technical Director and CTO of Undead Labs)

Dawon Entertainment joins Prytania Media as our first announced emerging-markets studio, based in Bangalore, India. Led by studio director and award-winning game designer Whitney Beltrán, Dawon is building culturally focused games by Indian developers for Indian players, embracing India’s captivating folklore, art, music, and cutting-edge technology sector.

Fang & Claw and Dawon Entertainment join sister studios Possibility Space and Crop Circle Games in the Prytania Media studios imprint.

About Prytania Media

Founded in 2021 by Annie Delisi Strain and Jeff Strain, Prytania Media is an independent, privately held portfolio of curated AAA development studios focused on the creation of groundbreaking new games on a global scale. Currently employing over 150 game development, business, and support staff around the world, Prytania Media also actively recruits, trains, and hires individuals from underserved/overlooked backgrounds into our family of studios through our Mosaic Initiative and Prytania Media Scholars programs.

About Crop Circle Games

Founded in 2021 as a Prytania Media studio and supported by early-stage investments totaling $23M by Transcend Fund and other strategic partners, Crop Circle Games is defining the next generation of narrative sandbox games for a global player community.

About Possibility Space

Founded in 2021 as a Prytania Media studio with $3M seed investment by Transcend Fund and in development partnership with a major publisher, Possibility Space is empowering a global creator community with an ambitious new social roleplaying platform.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media inquiries:
Elise Favis // Prytania Media
elise@prytania.co

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

MarkLines Gen-AI Beta Version Released for Automotive Industry13.1.2026 02:00:00 EET | Press release

MarkLines Co., Ltd. (Headquarters: Minato-ku, Tokyo; President & CEO: Makoto Sakai; TYO:3901) announced its launch of the "MarkLines Gen-AI Beta Version," the new feature for B2B users in the automotive industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112383839/en/ "MarkLines Gen-AI Beta Version" can take questions in natural language and instantly give highly reliable, relevant data drawn from MarkLines’ extensive automotive database (Image: MarkLines Co., Ltd.) This AI-powered feature enables users to ask questions in natural language and instantly receive highly reliable, relevant data drawn from MarkLines’ extensive automotive database. Moreover, the system analyzes this information by leveraging the rich content across its platform and delivers clear, concise, text-based insights. By combining trusted data with advanced analytical capabilities through generative AI, this service represents a first-of-its-kind

Australian Defence Force Secures Satellite Communications on SES IS-2212.1.2026 23:30:00 EET | Press release

Satellite communications solutions provider SES will provide secure uninterrupted satellite communications to the Australian Defence Force (ADF) for a minimum of 16 years thanks to a new extended agreement. The service will be provided via the SES Intelsat 22 satellite and an ultra-high frequency (UHF) military communications payload. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112137182/en/ Assistant Secretary Space Systems Branch, Michael Hunt, formalizes contract negotiations for the through-life support of the IS-22 satellite with Rory Welch, senior vice-president of service delivery at SES Space and Defense. Photos: Corporal Annika Smit Under the renewed arrangement, SES will reposition the IS-22 satellite to a new orbital slot specified by the ADF, continuing a mission that has been the cornerstone of Australia’s secure military communications since IS-22’s launch in 2012. SES will build a dedicated ground segmen

NetApp Appoints Paul Fipps to the Board of Directors12.1.2026 23:05:00 EET | Press release

NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced that Paul Fipps, President of Global Customer Operations at ServiceNow, has joined its Board of Directors. The board now has ten directors, nine of whom are independent, and 50% of whom have been appointed within the last five years. Fipps brings more than 20 years of experience driving technology-enabled growth and customer transformation. At ServiceNow, he currently leads global sales, customer success, partner ecosystems, and field operations. He previously served as EVP of Worldwide Sales at ServiceNow and as President of Under Armour Connected Fitness and Chief Experience Officer at Under Armour, overseeing global direct-to-consumer, connected fitness, and digital experiences. He also previously served on the advisory board of Quantum Metric. Fipps holds a B.S. in Information Systems, an MBA from the University of Baltimore, and is a graduate of The Wharton School’s Advanced Management Program. “P

FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor12.1.2026 21:00:00 EET | Press release

Merck, a leading science and technology company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application (NDA) for pimicotinib as a systemic treatment for patients with tenosynovial giant cell tumor (TGCT). The application is based on the primary results and longer-term follow-up of the global Phase 3 MANEUVER study, which demonstrated deep and durable tumor responses and meaningful improvements in clinical outcomes with pimicotinib. “With pimicotinib, we have an opportunity to significantly advance care for people living with TGCT, a painful and debilitating disease that has few effective and well-tolerated treatment options beyond surgery,” said David Weinreich, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “Based on clinical trial results showing not only a reduction in tumor burden, but also the ability to help alleviate symptoms like pain and stiffness in the global Phase 3 MANEUVER study

Fabentech receives Marketing Authorization for Ricimed®, an antidote against ricin poisoning12.1.2026 20:32:00 EET | Press release

Fabentech, a French biopharmaceutical company specializing in medical countermeasures against biological threats, today announces that it has been granted Marketing Authorization for Ricimed®, a treatment for ricin poisoning. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112241557/en/ Ricimed - Fabentech Ricimed®, an antidote against one of the most toxic natural substances in the world In addition to supportive care, and in severe situations requiring immediate administration, Ricimed® represents a new therapeutic option for the management of acute ricin intoxication. Ricin, among the most dangerous naturally occurring substances, can cause death within hours or days regardless of the route of exposure, making it a major biological threat for many countries. Having demonstrated its ability to specifically target and neutralize ricin before irreversible damage occurs, Ricimed® is an antibody-based therapy relying on poly

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye